10-Q: Quantum Computing Inc. Q2 Loss Widens Amid R&D Push
Quarterly Report
Quantum Computing Inc. reported a significant increase in net loss for Q2 2025, driven by higher operating expenses and a derivative liability loss, despite substantial capital raises.
Summary
- Net loss for the three months ended June 30, 2025, increased by 602% to $36.48 million, compared to $5.19 million in the prior year period.
- Revenue for Q2 2025 decreased by 67% to $61,000, down from $183,000 in Q2 2024.
- Research and development expenses surged by 185% to $5.98 million for Q2 2025, reflecting increased investment in product development.
- The company recognized a $28.10 million loss from the change in fair value of derivative liability in Q2 2025.
- Cash and cash equivalents significantly increased to $348.76 million as of June 30, 2025, up from $78.95 million at December 31, 2024, primarily due to recent capital raises.
- Working capital improved to $346.25 million as of June 30, 2025, from $74.59 million at December 31, 2024.
- The company settled multiple legal disputes with BV Advisory and Keith Barksdale, agreeing to pay $750,000 and issue 1.9 million common shares.
Sentiment
Score: 4
Explanation: The sentiment is mixed to slightly negative. While the company secured substantial capital, significantly improving its cash position and liquidity, it continues to report large and increasing net losses, declining revenue, and escalating operating expenses. The disclosure of ineffective disclosure controls and ongoing legal challenges further weigh on the sentiment, indicating operational and governance weaknesses despite the financial runway.
Positives
- Strong cash position with $348.76 million in cash and cash equivalents as of June 30, 2025, providing liquidity for the next 12 months.
- Successful capital raises in January and June 2025 generated aggregate gross proceeds of $300 million, significantly bolstering the balance sheet.
- Gross profit margin improved to 43% in Q2 2025 from 32% in Q2 2024, despite lower revenue, indicating better cost management on active contracts.
- Completion of the TFLN chip manufacturing facility in Tempe, Arizona, in March 2025, advancing long-term product development plans.
- Resolution of the BV Advisory legal proceedings, eliminating ongoing litigation and associated uncertainties.
Negatives
- Significant increase in net loss by 602% to $36.48 million for Q2 2025, primarily due to a large derivative liability loss.
- Revenue declined substantially by 67% in Q2 2025 and 52% for the six months ended June 30, 2025, indicating a contraction in sales and services.
- Operating expenses increased significantly, with R&D up 185%, sales and marketing up 59%, and G&A up 26% for Q2 2025, contributing to wider operating losses.
- The company's disclosure controls and procedures were deemed not effective as of June 30, 2025, raising concerns about financial reporting reliability.
- Accumulated deficit grew to $219.98 million as of June 30, 2025, reflecting continued unprofitability.
Risks
- The company operates in dynamic and highly competitive markets for high-performance conventional and quantum computing and cloud-based services.
- Competitors are actively developing new computing devices and enhancing cloud-based services, posing a competitive threat.
- Aggregate demand for solutions, services, and devices is correlated to global macroeconomic and geopolitical factors, which remain dynamic.
- Investments in quantum optical chips and devices are expected to increase operating costs and may decrease operating margins.
- Reliance on third-party manufacturers for device components, with very few qualified suppliers for certain parts, could lead to supply chain disruptions.
- The company's success is highly dependent on its ability to attract and retain qualified employees in a competitive talent market.
- Uncertain and unfavorable macroeconomic conditions, including inflationary pressures, rising interest rates, bank failures, and financial market fluctuations, could hinder access to capital.
- Future equity or convertible debt financings could dilute existing stockholders' ownership interests and may include restrictive covenants.
- Inability to raise additional funds when needed may force delays or reductions in product development and go-to-market efforts.
- The company's disclosure controls and procedures were not effective as of June 30, 2025, indicating potential risks in financial reporting and information communication.
- Ongoing legal proceedings, including a securities class action lawsuit and multiple shareholder derivative actions, could result in significant expenses and diversion of management attention.
- Stock price fluctuations could impact the fair value of the reporting unit and lead to potential goodwill impairment in future periods.
Future Outlook
The company expects to incur additional losses and higher operating expenses in the foreseeable future as it continues to invest in research and development and go-to-market programs. Significant cash will be required for the Foundry Services offering, potential expansion of the AZ Chips Facility, and ongoing R&D for non-linear quantum optical products and photonics chips. The company anticipates financing these needs through existing cash, equity/debt financings, or government grant/loan programs, believing current cash and future proceeds will cover liquidity needs for at least the next 12 months.
Management Comments
- We have not achieved a level of sales adequate to support the Company's cost structure.
- The Company has historically incurred losses and negative cash flows from operations.
- Our core photonics technology enables the execution of a go-to-market strategy which emphasizes scalability, accessibility and affordability.
- Our longer-term product development plan is to migrate product designs based on discrete components, including EQC's current design, to a set of optical integrated circuits built on wafers using a crystalline material called lithium niobate (Thin Film Lithium Niobate or TFLN).
- We anticipate that our EQC will enable us to develop and produce multiple generations of quantum machines with increasing computational power, scalability, and speed.
- The investments we are making in quantum optical chips and devices will continue to increase our operating costs and may decrease our operating margins.
- Our success is highly dependent on our ability to attract and retain qualified employees.
Industry Context
Quantum Computing Inc. operates in the nascent but rapidly evolving quantum computing and high-performance computing sectors. Its focus on room-temperature, low-power photonic quantum systems differentiates it from competitors using superconducting or ion-trap architectures, potentially offering a more scalable and accessible solution. The company's expansion into TFLN chip manufacturing aligns with the industry trend towards integrated photonics for quantum hardware, aiming to reduce costs and improve performance. However, the market remains highly competitive with established players and startups vying for technological breakthroughs and commercialization, and overall demand is sensitive to macroeconomic conditions.
Comparison to Industry Standards
- The company's revenue of $61,000 for Q2 2025 is extremely low for a publicly traded technology company, especially one in a high-growth, capital-intensive sector like quantum computing. This indicates it is still in a very early commercialization or development stage, far from generating significant sales comparable to established tech firms.
- The substantial net loss of $36.48 million for Q2 2025 is typical for a development-stage quantum computing company, as significant R&D investment is required. This is comparable to other quantum startups that are pre-revenue or early-revenue and heavily investing in technology development, such as IonQ or Rigetti Computing in their early stages, which also reported substantial losses while scaling R&D.
- The increase in R&D expenses by 185% to $5.98 million for Q2 2025 is consistent with the high investment required in quantum technology development, similar to the R&D spending patterns seen in companies like PsiQuantum or ColdQuanta, which are focused on hardware and integrated systems.
- The company's cash position of $348.76 million, largely due to recent capital raises, is robust for a company at this stage, providing a significant runway for operations and R&D. This cash balance is a strong point compared to many smaller, privately funded quantum startups that often face more immediate liquidity constraints.
- The disclosure of 'not effective' disclosure controls and procedures is a significant governance concern and falls below the standard expected of publicly traded companies, regardless of industry. This is a red flag that would typically not be seen in more mature or well-governed industry peers.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | NA | Christopher Roberts | 2025-06-20 | Employment Agreement dated June 20, 2025, indicating a formalization or new appointment in this role. |
| Former Executive | William McGann | NA | 2025-04-15 | Separation Agreement and General Release dated April 15, 2025. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Disclosure Controls and Procedures Effectiveness | Management concluded that disclosure controls and procedures were not effective to provide reasonable assurance that required information is recorded, processed, summarized, and reported timely, and communicated to management. | 2025-06-30 | This is a significant deficiency, indicating potential risks in the reliability of financial reporting and internal information flow, which could lead to misstatements or delayed disclosures. |
| Internal Control over Financial Reporting | No changes in internal control over financial reporting that materially affected or are reasonably likely to materially affect internal control over financial reporting during the most recent fiscal quarter. | 2025-06-30 | While no material changes occurred, the existing significant deficiencies and material weaknesses in internal control over financial reporting were disclosed to auditors and the audit committee, indicating ongoing issues. |
Legal Proceedings
- BV Advisory v. QCi Appraisal Action: Settled on July 17, 2025, with BV Advisory dismissing claims with prejudice.
- BV Advisory v. QCi Breach of Contract Lawsuit: Settled on July 17, 2025, with BV Advisory dismissing claims with prejudice.
- QCi v. BV Advisory Injunction Lawsuit: Settled on July 17, 2025, with parties dismissing claims with prejudice.
- Securities Class Action Lawsuit: Filed February 25, 2025, alleging violations of Section 10(b) and 20(a) of the Exchange Act due to alleged false/misleading statements about customers, contracts, and operations. Lead plaintiff to file amended complaint by August 26, 2025. Company disputes allegations.
- Shareholder Derivative Action Lawsuit (March 2025): Filed March 31, 2025, alleging breaches of fiduciary duties, unjust enrichment, abuse of control, waste of corporate assets, and Exchange Act violations. Stayed pending resolution of the Securities Class Action motion to dismiss.
- Shareholder Derivative Action Lawsuit (May 2025): Filed May 6, 2025, alleging breaches of fiduciary duties, gross mismanagement, waste of corporate assets, unjust enrichment, aiding and abetting, and Exchange Act violations. Stayed pending resolution of the Securities Class Action motion to dismiss.
- Shareholder Derivative Action Lawsuit (June 2025): Filed June 19, 2025, alleging breaches of fiduciary duties, waste, unjust enrichment, common law fraud, and Exchange Act violations. Parties are preparing a stipulation to stay the action.
- Stock Options Arbitration: Initiated in February 2025 with two former consultants regarding forfeited stock options. Company disputes claims.
Related Party Transactions
- No related party transactions were disclosed during the three and six months ended June 30, 2025 and 2024.
Stakeholder Impact
- Shareholders: Significant dilution from recent capital raises, but also a substantial increase in cash reserves providing a longer operational runway. Ongoing legal proceedings introduce uncertainty and potential financial liabilities. Ineffective disclosure controls could impact investor confidence.
- Employees: Increased R&D and operating expenses suggest continued investment in personnel and operations. The ability to attract and retain qualified employees is critical for the company's success.
- Customers: Revenue decline indicates a reduction in active customer contracts and services, potentially impacting customer relationships or market penetration.
- Creditors: Improved liquidity from capital raises reduces immediate credit risk, but continued losses and reliance on future financing remain factors.
- Suppliers: Reliance on third-party component manufacturers means disruptions could impact the company's ability to deliver products.
Next Steps
- Lead plaintiff in the securities class action lawsuit is required to file an amended complaint by August 26, 2025.
- The company and named defendants are scheduled to file a motion to dismiss the Securities Class Action on or before November 4, 2025.
- The company expects to continue investing in research and development for non-linear quantum optical products and photonics chips.
- Potential future expansion of the AZ Chips Facility for Foundry Services offering.
Key Dates
| Date | Description |
|---|---|
| 2025-01-07 | Company entered into securities purchase agreements for a private placement offering of 8,163,266 common shares at $12.25 per share. |
| 2025-01-09 | Closing of the January Private Placement, resulting in gross proceeds of $100 million. |
| 2025-02-03 | SEC declared effective the registration statement for the resale of the January Placement Shares. |
| 2025-02 | Company entered into arbitrations with two former consultants regarding the forfeiture of stock options. |
| 2025-02-25 | A class action lawsuit was filed against the Company and certain officers in the New Jersey District Court. |
| 2025-03 | Company substantially completed the buildout of a state-of-the-art TFLN chip manufacturing facility in Tempe, Arizona. |
| 2025-03-31 | A shareholder derivative action was filed against certain officers and directors in the United States District Court for the District of New Jersey. |
| 2025-05-06 | Another shareholder derivative action was filed against certain officers and directors in the United States District Court for the District of New Jersey. |
| 2025-06 | New Jersey District Court designated a lead plaintiff for the securities class action lawsuit. |
| 2025-06-19 | A third shareholder derivative action was filed against certain officers and directors in the United States District Court for the District of New Jersey. |
| 2025-06-20 | Employment Agreement between Quantum Computing Inc. and Christopher Roberts dated. |
| 2025-06-22 | Company entered into securities purchase agreements for a private placement of 14,035,089 common shares at $14.25 per share. |
| 2025-06-24 | Closing of the June Private Placement, resulting in gross proceeds of approximately $200 million. |
| 2025-06-30 | End of the quarterly reporting period. |
| 2025-07-03 | Company filed a registration statement on Form S-1 for the resale of the Placement Shares. |
| 2025-07-09 | Deadline for filing a registration statement for the resale of the Placement Shares. |
| 2025-07-14 | SEC declared effective the registration statement on Form S-1 for the resale of the Placement Shares. |
| 2025-07-17 | Company, BV Advisory, and Keith Barksdale entered into a settlement agreement for various legal disputes. |
| 2025-07-28 | Company filed a resale registration statement on Form S-1 related to the settlement agreement. |
| 2025-07-31 | Deadline for filing a registration statement for the resale of shares related to the settlement agreement. |
| 2025-08-04 | SEC declared effective the resale registration statement related to the settlement agreement. |
| 2025-08-13 | Date of common stock outstanding count (159,883,187 shares). |
| 2025-08-14 | Date of filing of the Quarterly Report on Form 10-Q. |
| 2025-08-26 | Deadline for the lead plaintiff to file an amended complaint in the securities class action lawsuit. |
| 2025-09-07 | End of lock-up period for directors and executive officers regarding common stock issuance. |
| 2025-11-04 | Deadline for the Company and named defendants to file a motion to dismiss the Securities Class Action. |
Recommendation
holdWhile Quantum Computing Inc. has significantly strengthened its balance sheet through substantial capital raises, providing a crucial liquidity runway for its ambitious R&D and commercialization efforts, the underlying operational performance remains weak. The company reported a sharp decline in revenue and a dramatic increase in net loss, exacerbated by a derivative liability adjustment. Furthermore, the disclosure of ineffective disclosure controls and the multitude of ongoing legal proceedings introduce significant governance and operational risks. For a seasoned investor, the current situation presents a high-risk, high-reward profile. The capital infusion mitigates immediate going concern risks and allows for continued development in a promising, albeit nascent, industry. However, the lack of revenue growth, escalating losses, and internal control deficiencies warrant a cautious approach. A 'hold' recommendation is appropriate to observe if the company can translate its R&D investments into tangible commercial success, address its governance shortcomings, and navigate its legal challenges effectively before committing further capital.
Keywords
Quantum Computing, Photonics, Entropy Quantum Computing, TFLN, Integrated Photonics, Quantum Optics, Qatalyst, Quantum Solutions, High-Performance Computing, Quantum Sensing, LIDAR, Reservoir Computing, Quantum Cybersecurity, SEC Filing, 10-Q
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.